12:00 AM
 | 
Sep 09, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

Alpine BioVentures financial update

Mitchell Gold, former president and CEO of immunotherapy cancer company Dendreon Corp. (NASDAQ:DNDN, Seattle, Wash.), and biotech analyst David Miller launched biotech hedge fund Alpine BioVentures. Miller...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >